1
|
Phanthawimol W, Komatsu Y, Hattori M, Naeemah Q, Shimoo S, Ota C, Ichihara N, Kimata A, Yamasaki H, Igarashi M, Nogami A. Left coronary cusp ablation to eliminate epicardial substrates – a novel strategy for left ventricular summit ventricular tachycardia ablation. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0757] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
Catheter ablation of LV summit VT can be challenging due to possible subepicardial or intramural site of origin and its close proximity to the major coronary vessels.
Objective
Local electrograms monitoring inside LV summit communicating vein potentially defines arrhythmogenic substrates and facilitates ablation from the adjacent anatomical structures.
Results
We experienced two cases of LV summit VT with epicardial local abnormal ventricular activities (Epi-LAVA) recorded from distal bipolar electrode of the 2F microcatheter in communicating vein close to the superior portion of LV summit. During sinus rhythm, Epi-LAVA displayed isolated late fractionated potentials in the first case but had initial fractionated potentials fused with terminal portion of far-field ventricular signals and late isolated potentials exhibiting 2:1 conduction in the second case. Epi-LAVA represented earliest ventricular signals during VT in both cases. Pace mapping at Epi-LAVA sites yielded single QRS morphology with excellent pacemap score and induced VT. Our strategy was to perform ablation at the facing site of Epi-LAVA aiming to eliminate the potentials transmurally. Radiofrequency (RF) energy was applied above and under the left coronary cusp opposite to Epi-LAVA sites using 3.5-mm tip open-irrigation catheter with a power of 30–35 W for 60 seconds under real-time intracardiac echocardiograhic guidance. VT was slowed and terminated in 1 second. Repeat ablation delayed and completely abolished Epi-LAVA followed by noninducibility of VT. Anatomical proximity of the left coronary cusp semilunar insertion and subepicardial or intramural site of origin possibly dictates successful ablation. Epi-LAVA from coronary vein mapping serve as a new landmark of the ablation target with a measurable procedural endpoint.
Conclusion
Elimination of epicardial substrates with RF energy application at the left coronary cusp can be a novel strategy for LV summit VT ablation.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
| | - Y Komatsu
- University of Tsukuba, Ibaraki, Japan
| | - M Hattori
- University of Tsukuba, Ibaraki, Japan
| | | | - S Shimoo
- University of Tsukuba, Ibaraki, Japan
| | - C Ota
- University of Tsukuba, Ibaraki, Japan
| | | | - A Kimata
- University of Tsukuba, Ibaraki, Japan
| | | | | | - A Nogami
- University of Tsukuba, Ibaraki, Japan
| |
Collapse
|
2
|
Marubashi S, Ichihara N, Kakeji Y, Miyata H, Taketomi A, Egawa H, Takada Y, Umeshita K, Seto Y, Gotoh M. "Real-time" risk models of postoperative morbidity and mortality for liver transplants. Ann Gastroenterol Surg 2019; 3:75-95. [PMID: 30697613 PMCID: PMC6345648 DOI: 10.1002/ags3.12217] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/01/2018] [Revised: 08/28/2018] [Accepted: 09/14/2018] [Indexed: 12/23/2022] Open
Abstract
AIM A comprehensive description of morbidity and mortality risk factors for post liver transplant has not been available to date. In this study, we established real-time risk models of postoperative morbidities and mortality in liver transplant recipients using two Japanese nationwide databases. METHODS Data from two Japanese nationwide databases were combined and used for this study. We developed real-time prognostic models for morbidity and mortality from a derivation cohort (n = 1472) and validated the findings with an independent cohort (n = 395). Preoperative variables (C1), preoperative and intraoperative variables (C2), and all variables including postoperative morbidities within 30 days (C3) were analyzed to evaluate the independent risk factors for postoperative morbidity and mortality. RESULTS We established real-time risk models for morbidity and mortality. Areas under the curve (AUC) of C1 and C2 risk models for mortality were 0.74 (0.63-0.82) and 0.79 (0.69-0.86), respectively. Multivariate logistic analysis using C3 showed that hemoglobin <10 g/dL, operative time (hours), and five postoperative morbidities (prolonged ventilation >48 hours, coma >24 hours, renal dysfunction, postoperative systemic sepsis, and serum total bilirubin ≥10 mg/dL) represented independent risk factors for mortality (AUC = 0.87, 95% confidence interval [CI]: 0.78-0.93). CONCLUSIONS Real-time risk models of postoperative morbidities and mortality at various perioperative time points in liver transplant recipients were established. These novel approaches may improve postoperative outcomes of liver transplant recipients. Furthermore, these real-time risk models may be applicable to other surgical procedures.
Collapse
Affiliation(s)
- Shigeru Marubashi
- Database Committee of Japanese Society of Gastroenterological SurgeryTokyoJapan
| | | | - Yoshihiro Kakeji
- Database Committee of Japanese Society of Gastroenterological SurgeryTokyoJapan
| | | | - Akinobu Taketomi
- Database Committee of Japanese Society of Gastroenterological SurgeryTokyoJapan
| | | | - Yasutsugu Takada
- Japanese Liver Transplant SocietyTokyoJapan
- Japanese Society of Hepato‐Biliary‐Pancreatic SurgeryTokyoJapan
| | | | - Yasuyuki Seto
- Japanese Society of Gastroenterological SurgeryTokyoJapan
| | | |
Collapse
|
3
|
Kumamaru H, Kohsaka S, Tomotaki A, Ichihara N, Iwanaka S, Miyata H. [Guideline Proposal for Use of Clinical Registries in Collaboration with Post Marketing Surveillance for Medical Devices]. Nihon Naika Gakkai Zasshi 2016; 105:2183-2193. [PMID: 30178982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
|
4
|
Motohashi M, Inomata T, Takahashi H, Ichihara N, Kansaku N, Ikegami M, Asari M, Mutou T, Wakui S. Three-Dimensional Study of the Terminal Portion in Sprague-Dawley Rat Ejaculatory Ducts. Anat Histol Embryol 2015; 45:285-90. [PMID: 26268523 DOI: 10.1111/ahe.12196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2015] [Accepted: 07/09/2015] [Indexed: 11/27/2022]
Abstract
In mammals, a pair of ejaculatory ducts exists in the urethra at the seminal colliculus. The detailed anatomical structures of the distal end of the ejaculatory ducts of Sprague-Dawley rats were investigated by the computer-assisted three-dimensional reconstruction analysis using light-microscopic serial sections. A three-dimensional reconstruction revealed that in adult rats, the ejaculatory sinus pair consists of two parts: the cranial section - a compartment region composed of a fusion of the ampullary gland duct and the seminal vesicle duct, and the caudal section - a grooved region composed of a long slitlike ejaculatory ostium that extends into the urethra on both sides of the seminal colliculus. But the sphincter structure was not observed. The long axis of the compartment region was approximately 58 μm in length, and that of the groove region was approximately 495 μm. Although many epithelial glands ducts were distributed throughout the ejaculatory sinuses, the prostate and coagulation gland ducts did not open in these sinuses. The urethra was composed of transitional epithelium, while the ejaculatory sinuses were composed of single to stratified cuboidal epithelium. The ejaculatory ducts continued to the ejaculatory ostium in male adult Sprague-Dawley rat were composed of the seminal vesicle ducts received the ampullary gland ducts.
Collapse
Affiliation(s)
- M Motohashi
- Department of Toxicology, Laboratory Animal Science, Animal Breeding, Genetics and Veterinary Anatomy, Azabu University School of Veterinary Medicine, Kanagawa, 252-5201, Japan
| | - T Inomata
- Department of Toxicology, Laboratory Animal Science, Animal Breeding, Genetics and Veterinary Anatomy, Azabu University School of Veterinary Medicine, Kanagawa, 252-5201, Japan
| | - H Takahashi
- Department of Pathology, the Jikei University School of Medicine, Tokyo, 105-8461, Japan
| | - N Ichihara
- Department of Toxicology, Laboratory Animal Science, Animal Breeding, Genetics and Veterinary Anatomy, Azabu University School of Veterinary Medicine, Kanagawa, 252-5201, Japan
| | - N Kansaku
- Department of Toxicology, Laboratory Animal Science, Animal Breeding, Genetics and Veterinary Anatomy, Azabu University School of Veterinary Medicine, Kanagawa, 252-5201, Japan
| | - M Ikegami
- Department of Pathology, the Jikei University School of Medicine, Tokyo, 105-8461, Japan
| | - M Asari
- Department of Toxicology, Laboratory Animal Science, Animal Breeding, Genetics and Veterinary Anatomy, Azabu University School of Veterinary Medicine, Kanagawa, 252-5201, Japan
| | - T Mutou
- Toxicololy and Pathology Research, SRICC, Sapporo, 004-0839, Japan
| | - S Wakui
- Department of Toxicology, Laboratory Animal Science, Animal Breeding, Genetics and Veterinary Anatomy, Azabu University School of Veterinary Medicine, Kanagawa, 252-5201, Japan
| |
Collapse
|
5
|
Ichihara N, Ishigami T, Umemura S. Effect of impaired renal function on the maintenance dose of warfarin in Japanese patients. J Cardiol 2014; 65:178-84. [PMID: 25442049 DOI: 10.1016/j.jjcc.2014.08.008] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/27/2014] [Revised: 07/22/2014] [Accepted: 08/10/2014] [Indexed: 02/06/2023]
Abstract
BACKGROUND Chronic kidney disease (CKD) alters dose-effect relationship not only of drugs eliminated by the kidney but also of some drugs metabolized by the liver and not renally excreted. It is not known whether impaired renal function alters dose-effect relationship of warfarin in Asian patients. It is also unknown whether the maintenance dose of warfarin can be predicted more accurately by incorporating renal function in Asians. METHODS This was a cross-sectional study of patients receiving constant doses of warfarin who had PT-INR within 1.5-3.0 for 3 months or longer. RESULTS In a total of 137 participants, the estimated creatinine clearance (eCrCl) was 62.5±25.5 [ml/min] and the warfarin dose was 3.21±1.46 [mg/day] (both mean±standard deviation). There was a significant correlation between warfarin dose and eCrCl (p<0.0001, r(2)=0.23). In a stepwise linear regression with the maintenance dose of warfarin as the dependent variable, eCrCl as well as age, body weight, intra-individual average prothrombin time/international normalized ratio (PT-INR), and genotype of VKORC1 -1639 G>A polymorphism were chosen as independent variables. The coefficient of determination (r(2)) of this formula was 0.47. A regression equation with all the same explanatory variables except for eCrCl had an r(2) of 0.41. CONCLUSIONS The maintenance warfarin dose was positively correlated with kidney function as represented by eCrCl in Japanese patients. Incorporating eCrCl improved accuracy of predicting warfarin maintenance dose in this population.
Collapse
Affiliation(s)
- Naoaki Ichihara
- Division of General Internal Medicine & Primary Care, Brigham and Women's Hospital, Boston, USA.
| | - Tomoaki Ishigami
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
| | - Satoshi Umemura
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
| |
Collapse
|
6
|
Nishikai M, Ichihara N, Bito S, Akiya K. Nondiabetic thigh muscle infarction presenting as a possible primary antiphospholipid syndrome. Mod Rheumatol 2014; 13:374-5. [DOI: 10.3109/s10165-003-0239-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
7
|
Kobayashi Y, Hirawa N, Tabara Y, Muraoka H, Fujita M, Miyazaki N, Fujiwara A, Ichikawa Y, Yamamoto Y, Ichihara N, Saka S, Wakui H, Yoshida SI, Yatsu K, Toya Y, Yasuda G, Kohara K, Kita Y, Takei K, Goshima Y, Ishikawa Y, Ueshima H, Miki T, Umemura S. Mice Lacking Hypertension Candidate Gene ATP2B1 in Vascular Smooth Muscle Cells Show Significant Blood Pressure Elevation. Hypertension 2012; 59:854-60. [DOI: 10.1161/hypertensionaha.110.165068] [Citation(s) in RCA: 67] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Affiliation(s)
- Yusuke Kobayashi
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Nobuhito Hirawa
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Yasuharu Tabara
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Hidenori Muraoka
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Megumi Fujita
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Nobuko Miyazaki
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Akira Fujiwara
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Yasuhiro Ichikawa
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Yuichiro Yamamoto
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Naoaki Ichihara
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Sanae Saka
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Hiromichi Wakui
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Shin-ichiro Yoshida
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Keisuke Yatsu
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Yoshiyuki Toya
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Gen Yasuda
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Katsuhiko Kohara
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Yoshikuni Kita
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Kohtaro Takei
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Yoshio Goshima
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Yoshihiro Ishikawa
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Hirotsugu Ueshima
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Tetsuro Miki
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| | - Satoshi Umemura
- From the Departments of Medical Science and Cardiorenal Medicine (Y.K., M.F., N.M., A.F., N.I., S.S., H.W., S.Y., Y.T., S.U.) and Molecular Pharmacology and Neurobiology (H.M., K.T., Y.G.) and Cardiovascular Research Institute (Y.Ic., Y.Is.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension (N.H., Y.Y., K.Y., G.Y.), Yokohama City University Medical Center, Yokohama, Japan; Department of Geriatric Medicine (Y.T., K.K., T.M.), Ehime
| |
Collapse
|
8
|
Wakui H, Tamura K, Tanaka Y, Matsuda M, Bai Y, Dejima T, Masuda SI, Shigenaga AI, Maeda A, Mogi M, Ichihara N, Kobayashi Y, Hirawa N, Ishigami T, Toya Y, Yabana M, Horiuchi M, Minamisawa S, Umemura S. Cardiac-Specific Activation of Angiotensin II Type 1 Receptor–Associated Protein Completely Suppresses Cardiac Hypertrophy in Chronic Angiotensin II–Infused Mice. Hypertension 2010; 55:1157-64. [DOI: 10.1161/hypertensionaha.109.147207] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
We cloned a novel molecule interacting with angiotensin II type 1 receptor, which we named ATRAP (for angiotensin II type 1 receptor–associated protein). Previous in vitro studies showed that ATRAP significantly promotes constitutive internalization of the angiotensin II type 1 receptor and further attenuates angiotensin II–mediated hypertrophic responses in cardiomyocytes. The present study was designed to investigate the putative functional role of ATRAP in cardiac hypertrophy by angiotensin II infusion in vivo. We first examined the effect of angiotensin II infusion on endogenous ATRAP expression in the heart of C57BL/6J wild-type mice. The angiotensin II treatment promoted cardiac hypertrophy, concomitant with a significant decrease in cardiac ATRAP expression, but without significant change in cardiac angiotensin II type 1 receptor expression. We hypothesized that a downregulation of the cardiac ATRAP to angiotensin II type 1 receptor ratio is involved in the pathogenesis of cardiac hypertrophy. To examine this hypothesis, we next generated transgenic mice expressing ATRAP specifically in cardiomyocytes under control of the α-myosin heavy chain promoter. In cardiac-specific ATRAP transgenic mice, the development of cardiac hypertrophy, activation of p38 mitogen-activated protein kinase, and expression of hypertrophy-related genes in the context of angiotensin II treatment were completely suppressed, in spite of there being no significant difference in blood pressure on radiotelemetry between the transgenic mice and littermate control mice. These results demonstrate that cardiomyocyte-specific overexpression of ATRAP in vivo abolishes the cardiac hypertrophy provoked by chronic angiotensin II infusion, thereby suggesting ATRAP to be a novel therapeutic target in cardiac hypertrophy.
Collapse
Affiliation(s)
- Hiromichi Wakui
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Kouichi Tamura
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Yutaka Tanaka
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Miyuki Matsuda
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Yunzhe Bai
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Toru Dejima
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Shin-ichiro Masuda
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Atsu-ichiro Shigenaga
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Akinobu Maeda
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Masaki Mogi
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Naoaki Ichihara
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Yusuke Kobayashi
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Nobuhito Hirawa
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Tomoaki Ishigami
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Yoshiyuki Toya
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Machiko Yabana
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Masatsugu Horiuchi
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Susumu Minamisawa
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| | - Satoshi Umemura
- From the Department of Medical Science and Cardiorenal Medicine (H.W., K.T., M.M., Y.B., T.D., S.M., A.S., A.M., N.I., Y.K., N.H., T.I., Y.T., M.Y., S.U.), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Molecular Cardiovascular Biology and Pharmacology (M.M., M.H.), Ehime University, Graduate School of Medicine, Ehime, Japan; Department of Life Science and Medical Bio-science (S.M.), Waseda University, Tokyo, Japan
| |
Collapse
|
9
|
Mizuno T, McKinnon A, Ichihara N, Amasaki T, Asari M, Nishita T, Oishi M, Soeta S, Amasaki H. Histological Structure and Distribution of Carbonic Anhydrase Isozymes (CA-I, II, III and VI) in Major Salivary Glands in Koalas. Anat Histol Embryol 2009; 38:449-54. [DOI: 10.1111/j.1439-0264.2009.00971.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
10
|
Sugiura Y, Soeta S, Ichihara N, Nishita T, Murakami M, Amasaki H, Amasaki T, Asari M. Immunohistolocalization and gene expression of the carbonic anhydrase isoenzymes (CA-II and CA-VI) in glands associated with the canine lacrimal apparatus. Anat Histol Embryol 2009; 39:1-6. [PMID: 19874279 DOI: 10.1111/j.1439-0264.2009.00966.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Cytosolic and secretory carbonic anhydrase isoenzymes (CA-II and CA-VI, respectively) were detected by immunohistolocalization using specific canine CA-II and CA-VI antisera. CA-II and CA-VI were identified in glands associated with the canine lacrimal apparatus, such as lacrimal gland, superficial gland of the third eyelid (third eyelid gland) and tarsal gland. CA-II and CA-VI mRNA signals were also detected by reverse-transcriptase polymerase chain reaction in the same tissues. Some serous acinar cells and duct segments in the lacrimal gland and serous acinar cells in the third eyelid gland were immunopositive for anti-CA-II and CA-VI antisera. In particular, some immunopositive acini to CA-II and CA-VI on the edge of the third eyelid gland are histologically similar to sebaceous gland cells. Sebaceous gland cells in the tarsal and ciliary glands also showed immunopositivity to both CA antisera. CA-II and CA-VI gene transcripts were detected in the same regions. These results suggest that secreted CA-VI may form together with cytosolic CA-II, a high-activity isozyme mostly considered as a bicarbonate producer, in a mutually complementary system for the maintenance of bicarbonate levels to regulate pH in tear fluid and protect the corneal epithelia against injuries. In sebaceous gland cells in the lacrimal apparatus, CA-VI may be related to lipogenesis in an unknown function.
Collapse
Affiliation(s)
- Y Sugiura
- Azabu University School of Veterinary Medicine, Fuchinobe, Sagamihara, Kanagawa, Japan
| | | | | | | | | | | | | | | |
Collapse
|
11
|
Ichihara N, Tsukamoto A, Kasuya T, Shibata S, Nishita T, Murakami M, Amasaki H, Asari M. Gene expression of secretory carbonic anhydrase isozymes in striated ducts of canine salivary glands using laser microdissection system. Anat Histol Embryol 2007; 36:357-60. [PMID: 17845225 DOI: 10.1111/j.1439-0264.2007.00774.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
To clarify whether striated duct cells in canine salivary glands synthesize secretory carbonic anhydrase (CA-VI), as is the case with serous acinar cells, the present study utilized laser microdissection to harvest striated duct cells from canine parotid and submandibular glands, and total RNA extracted from these cells was then amplified by reverse transcription-polymerase chain reaction to assess CA-VI gene expression. The results confirmed the local expression of CA-VI mRNA in striated duct cells. This clarified that, in canine salivary glands, CA-VI is synthesized in not only serous acinar cells, but also striated duct cells.
Collapse
Affiliation(s)
- N Ichihara
- Laboratory of Anatomy I, Azabu University School of Veterinary Medicine, Fuchinobe 1-17-71, Sagamihara, Kanagawa 229-8501, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
12
|
Abstract
The lymph drainage routes from the abdominal cavity in rats were observed at 3 min, 1, 2 and 4 h after India ink was administered intraperitoneally. Four systems of lymph drainage routes from the peritoneal cavity were observed. Three minutes after injection, the drainage route travelled via the intrathoracic lymph vessels located along the internal thoracic artery and returned to the anterior mediastinal lymph nodes. One hour after injection, the drainage route travelled via the lymph vessel located along the left phrenic nerve in addition to the drainage route observed at 3 min. Two and four hours after injection, in addition to the above-mentioned routes, the drainage that had travelled via the thoracic duct continued along the right side of the aorta and was also observed in the lateral lymph vessel located on the vertebra. These findings suggest that lymph or cells absorbed into the peritoneal cavity at first travel towards the anterior mediastinal lymph nodes in the thorax via the ventral lymphatic channels, and then gradually course through the dorsal lymphatic channels. These routes may serve as a route for transporting cancer cells and other cells from the peritoneal cavity.
Collapse
Affiliation(s)
- S Shibata
- First Department of Anatomy, Azabu University School of Veterinary Medicine, Fuchinobe 1-17-71, Sagamihara, Kanagawa 229-8501, Japan
| | | | | | | | | | | |
Collapse
|
13
|
Kasuya T, Shibata S, Kaseda M, Ichihara N, Nishita T, Murakami M, Asari M. Immunohistolocalization and Gene Expression of the Secretory Carbonic Anhydrase Isozymes (CA-VI) in Canine Oral Mucosa, Salivary Glands and Oesophagus. Anat Histol Embryol 2007; 36:53-7. [PMID: 17266669 DOI: 10.1111/j.1439-0264.2006.00721.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The immunohistolocalization of secretory carbonic anhydrase isoenzymes (CA-VI) in canine salivary glands, parotid, submandibular, sublingual and zygomatic glands, oral and oesophageal mucosa was studied using a specific antiserum against a canine CA-VI. In addition, the gene expression of CA-VI from the same tissue was studied using a real-time reverse-transcriptase polymerase chain reaction. In all salivary glands and oesophageal gland, immunostaining intensely localized CA-VI antiserum throughout the cytoplasm of serous acinar cells, including serous demilune and ductal epithelial cells. In contrast, no immunoreaction localized CA-VI in the mucous acinar cells of the gland. CA-VI gene transcripts were also detected in the same areas. The physiological significance of secretory CA-VI in the oral and oesophageal cavity is thought to play a highly specialized role in the maintenance of bicarbonate level in saliva and to protect mucosa from acid injury. It is shown that the major sites of the CA-VI secretion in dogs were in serous (demilune) secretory cells in all four major salivary glands and oesophageal glands in particular.
Collapse
Affiliation(s)
- T Kasuya
- Laboratory of Anatomy I, Azabu University School of Veterinary Medicine, Fuchinobe 1-17-71, Sagamihara, Kanagawa, 229-8501, Japan
| | | | | | | | | | | | | |
Collapse
|
14
|
Miyaji K, Suzuki M, Mizukami A, Iwatsuka R, Kumasaka R, Ichihara N, Nagahori W, Oono M, Arakawa T, Masaki N, Matsumura A, Hashimoto Y. Suppression of Ventricular Tachycardia Associated with Cardiac Sarcoidosis by Steroid Therapy. J Arrhythm 2007. [DOI: 10.1016/s1880-4276(07)80036-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
15
|
Nishita T, Tanaka Y, Wada Y, Murakami M, Kasuya T, Ichihara N, Matsui K, Asari M. Measurement of Carbonic Anhydrase Isozyme VI (CA-VI) in Bovine Sera, Saliva, Milk and Tissues. Vet Res Commun 2006; 31:83-92. [PMID: 17180448 DOI: 10.1007/s11259-006-3423-0] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/14/2005] [Indexed: 11/27/2022]
Abstract
Concentrations of bovine carbonic anhydrase isozyme VI (CA-IV) in bovine serum, saliva, normal milk, colostrum, submandibular gland, liver, and mammary gland were determined. CA-VI was purified from bovine saliva and an antibody to CA-VI was generated. The concentrations of CA-VI in the saliva (7.8 +/- 7.9 microg/ml), serum (2.1+/- 5.7 ng/ml), milk (7.9 +/- 12.1 ng/ml), submandibular gland (284.7 microg/g protein), liver (921.0 +/- 180.7 ng/g protein) and mammary gland (399.6 +/- 191.2 ng/g protein) were determined by ELISA. No seasonal change in CA-VI levels was observed in normal milk. The concentration of CA-VI in colostrum (day 1 post partum) was 119 ng/ml and decreased rapidly by 1 month following birth. Mammary gland contained much smaller amounts than the submandibular gland. CA-VI mRNA was detected in the liver and mammary gland of cow by RT-PCR. The ELISA used in this study proved to be a precise and sensitive method for determining CA-VI concentrations in saliva, serum, milk and tissue specimens from cows. The ELISA may enable the study of changes in CA-VI associated with hereditary or metabolic disorders of the salivary gland, mammary gland and liver using small samples of saliva, serum or milk.
Collapse
Affiliation(s)
- T Nishita
- Laboratory of Veterinary Physiology 1, School of Veterinary Medicine, Azabu University, Kanagawa, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
16
|
Yoshikawa S, Suzuki M, Ichihara N, Sato S, Arakawa T, Matsumura A, Hashimoto Y, Isobe M. [Interstitial pneumonitis followed by syndrome of inappropriate antidiuretic hormone secretion induced by amiodarone therapy for dilated cardiomyopathy: a case report]. J Cardiol 2006; 48:215-9. [PMID: 17066625] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
An 87-year-old man had been treated under a diagnosis of idiopathic dilated cardiomyopathy and sick sinus syndrome since 1996. His heart failure was worsened by atrial fibrillation in August 2004. He received amiodarone from October 2004. He was admitted to our hospital with shortness of breath in February 2005. Chest radiography revealed a diffuse reticular shadow in the right lung field and pleural effusion. The diagnosis was interstitial pneumonitis induced by amiodarone. However, 10 days after the discontinuation of amiodarone, the serum sodium concentration fell to 114mEq/l. The blood and urine chemical data were consistent with syndrome of inappropriate antidiuretic hormone secretion (SIADH). The serum sodium concentration improved with fluid restriction. Clinicians should be aware that SIADH may occur during amiodarone therapy.
Collapse
|
17
|
Nishikai M, Ichihara N, Bito S, Akiya K. Nondiabetic thigh muscle infarction presenting as a possible primary antiphospholipid syndrome. Mod Rheumatol 2003. [DOI: 10.1007/s10165-003-0239-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
18
|
Abstract
We prepared a map of the cleavage lines for beagle dogs, as a guideline for use of cleavage lines in dermatoplasty. The cleavage lines at the head resembled the orientation of the underlying muscles. Although the cleavage lines in the trunk were perpendicular to the body axis, those in the thoraco-abdominal region were parallel to the body axis. The cleavage lines at the limbs were parallel to the long axis of the limb on the cranial surface, but were perpendicular to the long axis of the limb on the lateral and caudal surfaces. Also, we recorded in detail the cleavage lines in the distal regions of the limbs.
Collapse
Affiliation(s)
- N Oiki
- Department of Anatomy and Physiology, Azabu University School of Veterinary Medicine, Sagamihara, Kanagawa, Japan
| | | | | | | | | | | |
Collapse
|
19
|
Naruse H, Tsuji A, Suzuki E, Watanabe N, Maeda M, Fukushi M, Ichihara N. Quality control system for mass screening in Japan. Southeast Asian J Trop Med Public Health 2003; 34 Suppl 3:30-5. [PMID: 15906689] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
Japan was the first country to establish a nationwide quality control system. When the Japanese Federal Government initiated Nationwide Neonatal Screening in 1977, the system officially included a Quality Control (QC) System that should cover all screening laboratories in Japan. This QC system is quite different from that for usual clinical chemistry. The aim of the National QC System for Neonatal Screening is evaluation of the accuracy of the tests and evaluation of the ability to detect suspicious samples with very mild abnormalities. For accomplishing the aim, the QC center established an inter-laboratory QC survey Screening laboratories having weak points can be identified through the inter-laboratory QC survey, and the Center must find a way to improve the ability of these screening laboratories. This requires a nationwide consensus regarding the cut-off levels of tested materials. Based on the cooperation of the Societies For Mass-screening, of Inborn Errors of Metabolism and of Pediatric Endocrinology, we set low cutoff levels for each compound to minimize the number of false negative cases. The system also included the evaluation of the quality of essential screening reagents and the special filter paper for blood collection (in partnership with the production companies). For this purpose, we developed some new methods for evaluating the standard-compounds for the various screening tests exactly, except in the case of TSH screening.
Collapse
Affiliation(s)
- H Naruse
- Quality Control Center for Mass-screening in Japan, Tokyo, Japan
| | | | | | | | | | | | | |
Collapse
|
20
|
Ichihara N, Okada M, Takeda M. Characterization and purification of polymorphic arylalkylamine N-acetyltransferase from the American cockroach, Periplaneta americana. Insect Biochem Mol Biol 2001; 32:15-22. [PMID: 11719065 DOI: 10.1016/s0965-1748(01)00075-3] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
We separated two forms of arylalkylamine N-acetyltransferase (AANAT) from various organs of the American cockroach, Periplaneta americana. Both forms of the enzyme had an equivalent molecular mass of 28 kDa. One form isolated from the testicular accessory glands had high enzyme activity at acidic pHs. The isoelectric point was 5-6 and the substrate specificity was wider than the other type. The other isolated form from female midguts had a higher level of enzyme activity at basic pHs. These findings suggested that P. americana contains polymorphic AANAT, as is the case in Drosophila melanogaster. These forms differed not only in pH specificity, and substrate specificity but in chromatographic behavior and kinetic properties. Most of the organs we examined contained a mixture of the two forms since two types of AANAT activity were separated in different chromatographic fractions when two pH conditions were used for activity measurement.
Collapse
Affiliation(s)
- N Ichihara
- Graduate School of Science and Technology, Kobe University, Nada-ku, 657-8570, Kobe, Japan
| | | | | |
Collapse
|
21
|
Amasaki T, Amasaki H, Nagasao J, Ichihara N, Asari M, Nishita T, Taniguchi K, Mutoh K. Immunohistochemical localization of carbonic anhydrase isoenzymes in salivary gland and intestine in adult and suckling pigs. J Vet Med Sci 2001; 63:967-70. [PMID: 11642284 DOI: 10.1292/jvms.63.967] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Localizations of carbonic anhydrase isoenzymes (CA I, CA II and CA III) were investigated immunohistochemically in the salivary glands and intestine of mature and suckling pigs. Carbonic anhydrase isoenzymes were not detected in the salivary glands of sucklings, but were present in the adult. Bicarbonate ion in saliva might be important for the digestion of solid foods in mature pigs, but unnecessary for the digestion of milk in sucklings. Expressions of CA I and CA II were detected strongly in the large intestine of the adult and sucklings, and faintly only at duodenum in the small intestine. CA I and CA II isoenzymes in the large intestine may be involved, at least in part, in ion absorption and water metabolism during digestion and absorption of milk in suckling pigs. In addition, CA I and CA II expression in the duodenal villus enterocyte may support the process of bicarbonate absorption in the duodenum.
Collapse
Affiliation(s)
- T Amasaki
- Department of Anatomy and Physiology, School of Veterinary Medicine, Azabu University, Sagamihara-shi, Japan
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Ichihara N, Ichihara SI, Fujii S, Touge T, Nishioka M. [An assessment of dysphagia using videofluorography in Parkinson's disease and progressive supranuclear palsy]. Rinsho Shinkeigaku 2000; 40:1076-82. [PMID: 11332186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
We assessed the oropharyngeal swallowing ability in 8 patients with Parkinson's disease (PD), 8 patients with progressive supranuclear palsy (PSP), and 10 age-matched healthy controls (CTL) using videofluorography (VF). In VF studies, PD and PSP patients demonstrated food pooling on the tongue, difficulty in bolus formation, and bolus falling into pharynx before swallow. PSP patients had a significantly longer delay in the pharyngeal phase and showed food falling into larynx more often than PD patients (p < 0.05). On measurement of swallowing time periods as proposed by Robbins et al., both patient groups showed significantly longer periods during many swallowing phases (P < 0.05) compared to those in the control group, but there were no significant differences between the PD and PSP groups. However, in PSP patients, the time for "transferring the food bolus from the oral cavity to pharynx" which we defined as a distinct stage was significantly longer (p < 0.05) than that in the PD group. We think that the difference in dysphagia characteristics between the two diseases arises from the variations in pathological changes in PSP, including those in the cerebral cortex, cerebellum, pons and medulla tegmentum in addition to the basal ganglia. Dystonia in the neck muscle also plays a role in dysphagia in PSP patients. Levodopa medication, changing the form of foods and training in rehabilitation techniques such as the chin down posture, supraglottic swallowing and ice-massage of the oral region are probably effective for dysphagia in PD patients. In patients with PSP, there are few research reports about the treatment of dysphagia. However, several dysphagia treatments seem to be useful depending on the abnormal patterns in the VF. Further studies are necessary to establish more effective treatments for dysphagia in PD and PSP.
Collapse
Affiliation(s)
- N Ichihara
- Department of Neurology, Takamatsu National Hospital
| | | | | | | | | |
Collapse
|
23
|
Asari M, Miura K, Ichihara N, Nishita T, Amasaki H. Distribution of carbonic anhydrase isozyme VI in the developing bovine parotid gland. Cells Tissues Organs 2000; 167:18-24. [PMID: 10899712 DOI: 10.1159/000016762] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
The distribution of bovine carbonic anhydrase isozyme VI (CA-VI), purified from bovine saliva, was studied immunohistochemically using antiserum against bovine CA-VI in bovine parotid glands during fetal and postnatal development. A weak expression of CA-VI in undifferentiated epithelial cells and ductal cells was observed in a 4- to 5-month-old fetus with a 26-cm crown-rump length. The reaction in both acinar and ductal cells subsequently persisted during late gestation and birth. Although anti-CA-VI reactivity was still seen in both regions immediately following birth, the reactivity had almost completely disappeared from most duct segments by 1 month following birth. Changes in the localization and time-dependent expression of the isozyme in parotid glands may reflect changes in the biological function of structurally closely related isozymes.
Collapse
Affiliation(s)
- M Asari
- Department of Anatomy and Physiology, Azabu University, School of Veterinary Medicine, Fuchinobe, Sagamihara, Japan.
| | | | | | | | | |
Collapse
|
24
|
Ichihara N, Deguchi K, Fujii S, Ishibashi T, Hatanaka Y. [A case of amyotrophic lateral sclerosis presenting with circulatory collapse during artificial respiration]. Rinsho Shinkeigaku 2000; 40:906-10. [PMID: 11257787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
A 71-year-old man developed dysarthria and difficulty of swallowing in December 1997. He was diagnosed as having the bulbar type of amyotrophic lateral sclerosis (ALS). In November 1998, he was admitted to our hospital to undergo treatment for bulbar palsy and respiratory discomfort. In January 1999, ventilatory support (synchronous intermittent mandatory ventilation) during sleep at night was initiated. Severe progressive hypotension and loss of consciousness were observed soon after the start of artificial respiration, and both symptoms disappeared after artificial respiration was discontinued. This phenomenon was observed consistently during ventilatory support, while unpleasant stimuli such as bronchoscopy and replacement of the cannula tube induced severe hypertension. To clarify the mechanism of underlying these abnormal changes in blood pressure, autonomic function tests were performed while awake during the daytime. Ventilatory support induced a drop in blood pressure accompanied by a decrease in influx speed to the right ventriculum, the latter of which suggested a reduction in venous return. These values returned to the baseline following detachment of the ventilator. A 60 degrees head-up tilt (HUT) angle and standing from a supine position produced orthostatic hypotension, the latter of which was accompanied by a compensatory increase in pulse rate. The basal supine plasma noradrenaline (NA) level was high and the HUT showed a slight elevation of NA. The basal supine plasma arginine vasopressin (AVP) level was within the normal range, whereas the AVP level did not increase during HUT. Urinary secretion rates of NA and 3-methoxy-4-hydroxy-phenylglycol were elevated. A cold pressor test demonstrated reflex hypertension. The oculovagal reflex, coefficient of variation of R-R intervals. (CVR-R) and increase in pulse rate in response to atropine administration were within the normal range. The combination of midodrine, L-dihydroxyphenylserine (DOPS) and increasing intravascular volume via continuous intravenous drip infusion relieved the circulatory collapse during artificial respiration. In conclusion, the present case of ALS had sympathetic hyperactivity, somatosympathetic reflex and dysregulation of the baroreflex arc. Degeneration of central autonomic network, including the hypothalamus and the central nucleus of the amygdala, which has been shown in some ALS patients, might underlie the autonomic abnormalities in this patient.
Collapse
Affiliation(s)
- N Ichihara
- Department of Neurology, Takamatsu National Hospital
| | | | | | | | | |
Collapse
|
25
|
Matsuyama S, Henmi S, Ichihara N, Sone S, Kikuchi T, Ariga T, Taguchi F. Protective effects of murine recombinant interferon-beta administered by intravenous, intramuscular or subcutaneous route on mouse hepatitis virus infection. Antiviral Res 2000; 47:131-7. [PMID: 10996401 DOI: 10.1016/s0166-3542(00)00097-8] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
The significance of the route for administration of murine recombinant interferon-beta (IFN-beta) for inducing its therapeutic effects has been studied. BALB/c mice were daily injected intravenously, intramuscularly or subcutaneously with 1.5x10(3), 1. 5x10(4), or 1.5x10(5) IU of IFN-beta, from one day before to 8th day after mouse hepatitis virus (MHV-2) challenge. All mice received IFN-beta survived significantly longer than those without IFN. In the liver of those IFN-treated mice, viral growth and the histopathological damages were extremely alleviated. These results suggest that, irrespective of the differences in the route of administration, IFN-beta markedly suppressed viral activity when its administration was started prior to viral infection. For clinical use, however, further studies are needed on the optimal route for administration if IFN-beta is given after viral infection.
Collapse
MESH Headings
- Animals
- Coronaviridae Infections/drug therapy
- Coronaviridae Infections/pathology
- Coronaviridae Infections/virology
- Hepatitis, Viral, Animal/drug therapy
- Hepatitis, Viral, Animal/pathology
- Hepatitis, Viral, Animal/virology
- Injections, Intramuscular
- Injections, Intravenous
- Injections, Subcutaneous
- Interferon Type I/administration & dosage
- Interferon Type I/therapeutic use
- Liver/drug effects
- Liver/pathology
- Liver/virology
- Male
- Mice
- Mice, Inbred BALB C
- Recombinant Proteins
Collapse
Affiliation(s)
- S Matsuyama
- National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, 187-8502, Tokyo, Japan
| | | | | | | | | | | | | |
Collapse
|
26
|
Touge T, Ichihara N, Ishibashi T, Ikeguchi M, Sasaki I, Takeuchi H. Afferent and efferent excitabilities of the transcortical loop in patients with dentatorubral-pallidoluysian atrophy. J Neurol Sci 2000; 176:28-36. [PMID: 10865089 DOI: 10.1016/s0022-510x(00)00294-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
To evaluate the excitabilities of the transcortical loop in patients with dentatorubral-pallidoluysian atrophy (DRPLA), we studied somatosensory evoked potentials (SEPs) and evoked EMG responses (V1 and V2) in 10 patients and age-matched controls. In addition, the facilitatory effects of somatosensory inputs on motor evoked potentials (MEPs) were studied in four patients and controls. We observed attenuated or prolonged cervical and subcortical potentials and prolonged middle latency components of SEPs. The amplitudes of V2 in patients were significantly lowered compared to those in the controls, while the amplitudes and latencies of V1 were similar between the two groups. Since V2 was considered as a transcortical reflex, our results suggest reduced excitabilities of the afferent pathway of the transcortical loop in patients with DRPLA. Median nerve stimulation (MNS) 25 to 30 ms preceding transcranial magnetic stimulation (TMS) facilitated MEPs in the thenar muscle in two of the four patients and in the controls. The facilitation of MEPs by MNS tended to be independent of the reduction in V2. Such a result suggests that different neural mechanisms elicit V2 and facilitate MEPs following peripheral nerve stimulation, although further studies are needed. The combination of SEPs, evoked EMG responses and MEPs may be a useful technique to detect abnormalities of input and output coordinations of the transcortical loop.
Collapse
Affiliation(s)
- T Touge
- Third Department of Internal Medicine, Kagawa Medical University, 1750-1, Ikenobe, Miki-cho, Kita-gun, Kagawa, Japan.
| | | | | | | | | | | |
Collapse
|
27
|
Asari M, Kimura H, Ichihara N, Kasuya T, Nishita T. Immunohistochemistry of carbonic anhydrase isozymes (CA-I, II and III) in canine salivary glands: a distributional and comparative assessment. Anat Histol Embryol 2000; 29:9-12. [PMID: 10820896 DOI: 10.1046/j.1439-0264.2000.00234.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The immunohistolocalization of carbonic anhydrase isozymes (CA-I, II, III) in canine salivary glands was studied using antiserum against CA-I, II, III. In parotid glands, immunostaining intensely localized cytosolic CA-II antiserum throughout the cytoplasm of acinar secretory cells and ductal epithelial cells, especially in the striated duct region. CA-III reactivity in the glands was only seen selectively at the intercalated ductal cells. In contrast, no immunoreaction localized CA-I in the gland. In the submandibular and sublingual glands, CA-I, II, and III were all observed in the ductal segments of the glands, whereas serous demilune appeared devoid of all three cytosolic CA isozymes. In contrast, in zygomatic glands (i.e. dorsal buccal glands) all CA isozymes were observed in both serous demilune and ductal segments. In all of the salivary glands examined, no mucous acinar cells were found to be reactive for any CA.
Collapse
Affiliation(s)
- M Asari
- Department of Anatomy and Physiology, Azabu University, School of Veterinary Medicine, Kanagawa, Japan.
| | | | | | | | | |
Collapse
|
28
|
Abstract
AIM To determine if the diuretic spironolactone cross reacts with 17alpha-hydroxyprogesterone (17OHP) in an enzyme linked immunosorbent assay (ELISA) kit used for the mass screening of congenital adrenal hyperplasia. METHODS Concentrations of 17OHP on a blood filter paper disc were measured using an ELISA kit (kit C-7: ENZAPLATE N-17alpha -OHP-7; Chiron, Tokyo, Japan). The cross reactivity of spironolactone and its metabolites with 17OHP was determined. The concentrations of spironolactone and its metabolites in blood were measured using HPLC (high performance liquid chromatography). RESULTS Spironolactone cross reacted with 17OHP using kit C-7 (0.01%), by increasing 17OHP concentration in a dose dependent manner. The blood concentration of spironolactone and its metabolites was nearly 900 ng/ml, high enough to show an additive effect on the 17OHP concentration. About 12% of the false positive cases screened using the kit were due to the administration of spironolactone. CONCLUSIONS Spironolactone interferes with 17OHP concentrations, leading to false positive test results for CAH.
Collapse
Affiliation(s)
- I Terai
- Division of Clinical Pathology, Hokkaido Institute of Public Health, Sapporo 060, Japan.
| | | | | | | | | |
Collapse
|
29
|
Ando Y, Ichihara N, Takeshita S, Nagata M, Kimura T, Tanase H, Kikuchi T. A new neurological mutant rat with symmetrical calcification of Purkinje cells in cerebellum. Proc Soc Exp Biol Med 1999; 221:361-8. [PMID: 10460698 DOI: 10.1046/j.1525-1373.1999.d01-93.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
A new neurological mutant has been found in the inbred F344 strain of rats. The mutation is inherited as an autosomal recessive trait and is manifest clinically by a hesitant and wobbling gait with asynergic limbs and slight tremor. These symptoms begin at 16-18 days of age and remain essentially constant thereafter. Histologic examination revealed severe degeneration of the Purkinje cells and symmetrical calcification in these and in their dendritic branches in the cerebellar cortex. Such calcified Purkinje cells were intensely stained with the periodic acid-Schiff (PAS) method. PAS-positive substances in the Purkinje cells and extending diffusely over the lesioned sites in the molecular layer were also evident before calcification took place. We have named this neurological mutant the Cerebellar Calcification (CC) rat with the gene symbol cc. This offers a new animal model for the study of the Purkinje cell degeneration and intracranial calcification.
Collapse
Affiliation(s)
- Y Ando
- Laboratory Animal Science and Toxicology Laboratories, Sankyo Co., Ltd., Fukuroi, Shizuoka 437-0065, Japan
| | | | | | | | | | | | | |
Collapse
|
30
|
Saigoh K, Wang YL, Suh JG, Yamanishi T, Sakai Y, Kiyosawa H, Harada T, Ichihara N, Wakana S, Kikuchi T, Wada K. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet 1999; 23:47-51. [PMID: 10471497 DOI: 10.1038/12647] [Citation(s) in RCA: 396] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
The gracile axonal dystrophy (gad) mouse is an autosomal recessive mutant that shows sensory ataxia at an early stage, followed by motor ataxia at a later stage. Pathologically, the mutant is characterized by 'dying-back' type axonal degeneration and formation of spheroid bodies in nerve terminals. Recent pathological observations have associated brain ageing and neurodegenerative diseases with progressive accumulation of ubiquitinated protein conjugates. In gad mice, accumulation of amyloid beta-protein and ubiquitin-positive deposits occur retrogradely along the sensory and motor nervous systems. We previously reported that the gad mutation was transmitted by a gene on chromosome 5 (refs 10,11). Here we find that the gad mutation is caused by an in-frame deletion including exons 7 and 8 of Uchl1, encoding the ubiquitin carboxy-terminal hydrolase (UCH) isozyme (Uch-l1) selectively expressed in the nervous system and testis. The gad allele encodes a truncated Uch-l1 lacking a segment of 42 amino acids containing a catalytic residue. As Uch-l1 is thought to stimulate protein degradation by generating free monomeric ubiquitin, the gad mutation appears to affect protein turnover. Our data suggest that altered function of the ubiquitin system directly causes neurodegeneration. The gad mouse provides a useful model for investigating human neurodegenerative disorders.
Collapse
Affiliation(s)
- K Saigoh
- Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, 187-8502, Japan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Sasaki I, Fujii S, Ichihara N, Hatanaka Y. [Vitamin B1 deficiency polyneuropathy presenting homolateral imitative synkinesia]. No To Shinkei 1999; 51:638-40. [PMID: 10457953] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
We report a 56-year-old woman with vitamin B1 polyneuropathy, showing bilateral homolateral imitative synkinesia. Needle electromyogram revealed neurogenic changes, and the amplitude of muscle action potential was low. Sural nerve biopsy showed a marked loss of myelinated fibers, and severe axonal degeneration was diagnosed. Spinal and brain MRI revealed no abnormalities. In the literature, these synkinesias were observed in patients with parietal, thalamic, and basal ganglia lesions and with chorea. We suggest that this synkinesia is the release phenomenon in the circuit of the motor programming system due to the disturbance of peripheral nerve or funiculus posterior.
Collapse
Affiliation(s)
- I Sasaki
- Department of Neurology, Takamatsu National Hospital, Kagawa-ken, Japan
| | | | | | | |
Collapse
|
32
|
Tsujino S, Kinoshita N, Tashiro T, Ikeda K, Ichihara N, Kikuchi H, Hagiwara Y, Mizutani M, Kikuchi T, Sakuragawa N. Adenovirus-mediated transfer of human acid maltase gene reduces glycogen accumulation in skeletal muscle of Japanese quail with acid maltase deficiency. Hum Gene Ther 1998; 9:1609-16. [PMID: 9694159 DOI: 10.1089/hum.1998.9.11-1609] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Acid maltase deficiency (AMD) causes a lysosomal glycogenosis inherited as an autosomal recessive trait. The infantile type of AMD (Pompe disease) leads to early death due to severe dysfunction of cardiac and respiratory muscles and no effective therapy is available. Replication-defective adenovirus vectors offer a promising tool for in vivo gene delivery and gene therapy. We constructed a recombinant adenovirus containing the human acid maltase (AM) cDNA downstream of the CAG promoter, composed of modified chicken beta-actin promoter and CMV IE enhancer (AxCANAM). Japanese quail with AMD was used for this study as an animal model for human AMD. When cultured fibroblasts from AMD quail were infected with AxCANAM, AM activity in the cells increased in proportion to the multiplicity of infection (MOI). When AxCANAM (4.5 x 10(8) PFU) was injected into unilateral superficial pectoral muscle of AMD quail, PAS staining showed that glycogenosomes disappeared and stainability of acid phosphatase was reduced in the injected area as compared with the contralateral muscle of the same birds. Biochemically, AM activity increased and glycogen content decreased in the injected muscle. Western blot analysis showed that AMD quail muscle injected with AxCANAM expressed human AM protein processed to active forms. These results suggest that the human AM cDNA transferred by an adenovirus vector was sufficiently expressed, leading to a marked reduction of the glycogen accumulation in the skeletal muscle of AMD quail.
Collapse
Affiliation(s)
- S Tsujino
- Department of Inherited Metabolic Disease, National Institute of Neuroscience, NCNP, Kodaira, Tokyo, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Kikuchi T, Yang HW, Pennybacker M, Ichihara N, Mizutani M, Van Hove JL, Chen YT. Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail. J Clin Invest 1998; 101:827-33. [PMID: 9466978 PMCID: PMC508631 DOI: 10.1172/jci1722] [Citation(s) in RCA: 133] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Pompe disease is a fatal genetic muscle disorder caused by a deficiency of acid alpha-glucosidase (GAA), a glycogen degrading lysosomal enzyme. GAA-deficient (AMD) Japanese quails exhibit progressive myopathy and cannot lift their wings, fly, or right themselves from the supine position (flip test). Six 4-wk-old acid maltase-deficient quails, with the clinical symptoms listed, were intravenously injected with 14 or 4.2 mg/kg of precursor form of recombinant human GAA or buffer alone every 2-3 d for 18 d (seven injections). On day 18, both high dose-treated birds (14 mg/kg) scored positive flip tests and flapped their wings, and one bird flew up more than 100 cm. GAA activity increased in most of the tissues examined. In heart and liver, glycogen levels dropped to normal and histopathology was normal. In pectoralis muscle, morphology was essentially normal, except for increased glycogen granules. In sharp contrast, sham-treated quail muscle had markedly increased glycogen granules, multi-vesicular autophagosomes, and inter- and intrafascicular fatty infiltrations. Low dose-treated birds (4.2 mg/kg) improved less biochemically and histopathologically than high dose birds, indicating a dose-dependent response. Additional experiment with intermediate doses and extended treatment (four birds, 5.7-9 mg/kg for 45 d) halted the progression of the disease. Our data is the first to show that an exogenous protein can target to muscle and produce muscle improvement. These data also suggest enzyme replacement with recombinant human GAA is a promising therapy for human Pompe disease.
Collapse
Affiliation(s)
- T Kikuchi
- Department of Animal Models for Human Disease, National Institute of Neuroscience, NCNP, Tokyo 187, Japan
| | | | | | | | | | | | | |
Collapse
|
34
|
Ichihara N, Sasaki K, Iseri S, Kimura H, Miura K, Nishita T, Asari M. Immunohistolocalization of carbonic anhydrase isozymes (CA-I, CA-II and CA-III) in bovine male reproductive tracts. Okajimas Folia Anat Jpn 1997; 74:193-8. [PMID: 9446931 DOI: 10.2535/ofaj1936.74.5_193] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Immunohistochemical localizations of carbonic anhydrase isozymes (CA-I, CA-II and CA-III) in bovine male reproductive tracts were studied. In bulls, no immunoreaction was seen after treatment with antibodies to CA-I, -II and CA-III in the testis. Specific staining for CA-III, however, was evident in peritubular cells in interstitial tissue of the testis, epididymis. CA-II activity could be detected in epithelium of the epididymis, ductus deferentis and ampulla ductus deferentis. Especially, a strong reaction for CA-II was seen in apical in epithelium of the epididymis in the initial and middle segment. CA-I activity was only founded in ductus deferentis and ampulla ductus deferentis. No or a weak reaction for CA-I, CA-II and CA-III were seen in the three accessory reproductive glands. Specific immunostaining for CA-II and CA-I could be observed in the organ, suggesting the bicarbonate in bovine semen to derive primarily from the genital tract and not accessory reproductive organs. CA-III-positive peritubular cells in interstitial tissue were also stained for alpha smooth muscle actin, and were very similar to contractile myofibroblast cells (Wrobel et al., 1979).
Collapse
Affiliation(s)
- N Ichihara
- Department of Animal Models for Human Disease, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan
| | | | | | | | | | | | | |
Collapse
|
35
|
Suh JG, Ichihara N, Saigoh K, Nakabayashi O, Yamanishi T, Tanaka K, Wada K, Kikuchi T. An in-frame deletion in peripheral myelin protein-22 gene causes hypomyelination and cell death of the Schwann cells in the new Trembler mutant mice. Neuroscience 1997; 79:735-44. [PMID: 9219937 DOI: 10.1016/s0306-4522(96)00692-6] [Citation(s) in RCA: 25] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Cloning and sequencing of the peripheral myelin protein-22 cDNA and genomic DNA from newly found Trembler mice revealed an in-frame deletion including exon IV which codes for the second (TM2) and a part of third (TM3) transmembrane domain of peripheral myelin protein-22. This mutation was distinct from those in both other allelic Trembler and Trembler-J mice, which carry point mutations within the putative transmembrane spanning regions of peripheral myelin protein-22. Inheritance was autosomal dominant. The affected mice revealed an abnormal gait, which appeared at 15-20 days of age, followed by motor and sensory ataxia, which remained throughout life. Most of the affected mice could survive more than one year. One of the most notable pathological phenotypes was a giant vacuolar formation in the sciatic nerve of homozygotes. They vary in size within the cytoplasm of Schwann cells, which failed to assemble myelin at any ages studied. Heterozygotes showed normal myelination during the early postnatal stages, followed by a segmental demyelination at an advanced stage. Vacuolar formation was not so frequent as in the homozygotes. These results suggest that the missing of transmembrane spanning region (TM2 and TM3) of peripheral myelin protein-22 may disturb a dual biological function of peripheral myelin protein-22, leading to a dysmyelination of axons and to a vacuolar formation within the cytoplasm of the Schwann cells. The latter phenotype is discussed in conjunction with the disruption of an intracellular transport system and subsequent cell death.
Collapse
Affiliation(s)
- J G Suh
- Department of Animal Models for Human Disease, National Institute of Neuroscience, NCNP, Kodaira, Tokyo, Japan
| | | | | | | | | | | | | | | |
Collapse
|
36
|
Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T, Ichihara N, Kikuchi T, Okuyama S, Kawashima N, Hori S, Takimoto M, Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997; 276:1699-702. [PMID: 9180080 DOI: 10.1126/science.276.5319.1699] [Citation(s) in RCA: 1318] [Impact Index Per Article: 48.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Extracellular levels of the excitatory neurotransmitter glutamate in the nervous system are maintained by transporters that actively remove glutamate from the extracellular space. Homozygous mice deficient in GLT-1, a widely distributed astrocytic glutamate transporter, show lethal spontaneous seizures and increased susceptibility to acute cortical injury. These effects can be attributed to elevated levels of residual glutamate in the brains of these mice.
Collapse
Affiliation(s)
- K Tanaka
- Department of Degenerative Neurological Diseases, National Institute of Neuroscience, Kodaira, Tokyo 187, Japan.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Touge T, Takeuchi H, Sasaki I, Deguchi K, Ichihara N. Enhanced amplitude reduction of somatosensory evoked potentials by voluntary movement in the elderly. Electroencephalogr Clin Neurophysiol 1997; 104:108-14. [PMID: 9146476 DOI: 10.1016/s0168-5597(97)96136-0] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
We studied the effects of aging on modification of the median nerve somatosensory evoked potentials (SEPs) by voluntary movement in 17 aged (66.5 +/- 8.9 years, mean +/- SD) and 12 young normal humans (27.5 +/- 5.0 years). The amplitudes of cortical SEP components were generally larger in the aged group than in the young group. Following isometric contraction of the thenar muscle, the aged group showed significant attenuation of the prerolandic P22-N28-P45 and the postrolandic P24-N30-P45, while the young group only demonstrated significant reduction of the prerolandic P22-N28 amplitude. In the prerolandic N28-P45 and the postrolandic P24-N30 and N30-P45, amplitudes reduced by voluntary movement (gated amplitude) significantly correlated with amplitudes at rest (resting amplitude) and with the age of subjects. The effects of stimulus intensity and frequency on gating supported the correlative changes between gated and resting amplitudes. These results suggest that the magnitude of gating depends on SEP amplitudes at rest, and that augmented gating in the aged group is a result of enlarged SEPs. Since the cervical and Erb's potentials were not changed by movement, and passive movement did not significantly affect the SEPs, a centrifugal mechanism is probably responsible for gating in this study.
Collapse
Affiliation(s)
- T Touge
- Third Department of Internal Medicine, Kagawa Medical University, Japan
| | | | | | | | | |
Collapse
|
38
|
Ichihara N, Okada M, Nakagawa H, Takeda M. Purification and characterization of arylalkylamine N-acetyltransferase from cockroach testicular organs. Insect Biochem Mol Biol 1997; 27:241-246. [PMID: 9090119 DOI: 10.1016/s0965-1748(96)00091-4] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
Arylalkylamine N-acetyltransferase (NAT; EC2.3.1.87) catalyzes N-acetylation of various arylalkylamines using acetyl-CoA as a donor substrate. A type of NAT was purified 2700-fold from 451 pairs of cockroach testicular organs consisting of testis and its accessory gland. The NAT activity was recovered as a single peak on any column chromatography examined, suggesting that the testicular organ contained only one form of NAT. Five steps of successive column chromatographies gave a single protein band on SDS-polyacrylamide gel electrophoresis with estimated molecular mass of 28 kDa. The molecular mass of the native enzyme was also determined to be approximately 30 kDa by molecular sieve chromatography, indicating that the enzyme is a monomer protein. The enzyme acted on various arylalkylamines such as tryptamine, serotonin, dopamine, octopamine, norepinephrine, tyramine and methoxytryptamine, with K(m) values ranging from 20 to 50 microM. The optimum pH for these substrates was around 6.0. Internal amino acid sequences derived from two proteolytic fragments of the enzyme were determined as Leu-Leu-Gly-Glu-Asn-Gly-Asp-Glu and Phe-Phe-Phe-Leu-Glu-Glu-Pro-Leu-Asn-Ile-Ser-Leu-Gln, both of which exhibited significant homology to the C-terminal sequence of known vertebrate NATs; however, homology was less than 45%. These results suggest that a unique NAT is present in the cockroach testicular organ at high levels, and likely plays a role in the regulation of testicular function.
Collapse
Affiliation(s)
- N Ichihara
- Laboratory of Insect Science, Faculty of Agriculture, Kobe University, Japan
| | | | | | | |
Collapse
|
39
|
Igarashi S, Miura K, Ichihara N, Kano Y, Nishita T, Asari M, Amasaki H. Expression of carbonic anhydrase isozymes (CA-I, CA-II, CA-III) during postnatal development of the rat gastrointestinal tract. Ann Anat 1996; 178:369-73. [PMID: 8817044 DOI: 10.1016/s0940-9602(96)80098-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Affiliation(s)
- S Igarashi
- Toxicology Laboratory, Chugai Pharmaceutical Co., Ltd., Nagano, Japan
| | | | | | | | | | | | | |
Collapse
|
40
|
Asari M, Sasaki K, Miura K, Ichihara N, Nishita T. Immunohistolocalization of the carbonic anhydrase isoenzymes (CA-I, CA-II, and CA-III) in the reproductive tract of male horses. Am J Vet Res 1996; 57:439-43. [PMID: 8712504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
OBJECTIVE To elucidate locations of cytosolic carbonic anhydrase isoenzyme (CA-I, CA-II, and CA-III)-positive epithelial cells in equine male reproductive organs. DESIGN Descriptive and immunohistochemical study. ANIMALS 4 clinically normal male horses. PROCEDURE The testis (seminiferous tubules, rete tubules), epididymis (initial, middle, and terminal segments), proximal and distal portions of the ductus deferens, ampulla ductus deferentis, seminal vesicle, prostate, and bulbourethral gland were excised from euthanatized horses after administration of an overdose of pentobarbital. The tissue specimens were quickly placed in fixative solution, dehydrated in ethanol, and embedded; then thin sections were cut. For immunohistochemical staining, antibodies against purified equine CA-I, CA-II, and CA-III were raised in rabbits. After examination of the specificity of each antiserum, the monospecific antisera against carbonic anhydrase isoenzymes were used to localize the isoenzymes. RESULTS Specific staining for CA-III was found in the Sertoli and basal cells of the ductus deferens. Most of the testicular and epididymal tissue, as well as ductus deferens, were virtually negative for the enzymes when stained with the antibody to CA-I and CA-II. In the initial segment of the epididymis, a few principal cells had intense cytoplasmic staining with anti-CA-II. In the male accessory glands, CA-I, CA-II, and CA-III were detected in the epithelial cells of the seminal vesicle, prostate, and bulbourethral gland. CONCLUSIONS In the equine male reproductive tract, the bicarbonate in semen originates mainly from accessory reproductive glands. All 3 isoenzymes may have central roles in the regulation of bicarbonate concentration in seminal plasm and, accordingly, regulate seminal plasma pH. Distribution of CA-III in Sertoli and basal cells of the ductus deferens suggests other specialized physiologic roles.
Collapse
Affiliation(s)
- M Asari
- Department of Anatomy I, School of Veterinary Medicine, Azabu University, Kanagawa, Japan
| | | | | | | | | |
Collapse
|
41
|
Ichihara N, Wu J, Chui DH, Yamazaki K, Wakabayashi T, Kikuchi T. Axonal degeneration promotes abnormal accumulation of amyloid beta-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse. Brain Res 1995; 695:173-8. [PMID: 8556328 DOI: 10.1016/0006-8993(95)00729-a] [Citation(s) in RCA: 54] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
The GAD mouse is a spontaneous neurological mutant with axonal dystrophy in the gracile tract of the medulla oblongata and spinal cord. The immunoreactivity of amyloid precursor protein (APP-IR) and amyloid beta-protein (A beta P-IR) was examined in the gracile tract and the dorsal root ganglia of normal and GAD mice. The mice were studied at 4, 9, 18, and 32 weeks of age. These periods correspond clinically to the initial, progressive, critical, and terminal stages of the disease, respectively. The APP-IR in both axons and glial cells was already accentuated to a higher level as early as 4 weeks of age in the gracile nucleus of GAD mouse. Similarly there was increase in APP-IR of GAD mouse in the dorsal root ganglia. Almost all of the primary neurons in the dorsal root ganglia at the lumbar cord level of GAD mouse revealed stronger APP-IR than those of normal mouse throughout all stages. The cells showing immunoreactivity for amyloid beta-protein became positive in axons and glial cells in the gracile nucleus by approximately the 9th week, and followed by an increase of A beta P-IR in order of the cervical, thoracic and lumbar spinal cords. These results suggest that the initial feature in GAD mouse is an accumulation of amyloid precursor protein induced by axonal dystrophy which then leads to a deposition of amyloid beta-protein within the cytoplasm of both axons and glial cells in the gracile tract.
Collapse
Affiliation(s)
- N Ichihara
- Department of Animal Models for Human Disease, National Institute of Neuroscience, Tokyo, Japan
| | | | | | | | | | | |
Collapse
|
42
|
Wu J, Ichihara N, Chui DH, Yamazaki K, Kikuchi T. [Ubiquitin immunoreactivity in the central nervous system of gracile axonal dystrophy (GAD) mouse]. No To Shinkei 1995; 47:881-5. [PMID: 7546937] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
In order to know the relationship of ubiquitin and axonal degeneration in the central nervous system (CNS) of the gracile axonal dystrophy (GAD) mutant mouse, the immunocytochemical study was performed in the spinal cord, medulla oblongata and brain of normal and GAD mice at 4, 9, 18 and 32 weeks of age. The polyclonal antibodies of ubiquitin were used for this study. The results were as follows: Many ubiquitin-positive dot-like structures (DS) were first observed in the gracile nucleus affected primarily with axonal degeneration. They extended to the gracile fasciculus on the dorsal part of spinal cord in accordance with the dying-back type degeneration. The second-order neurons at Clarke's nucleus were also affected slightly later stages and revealed ubiquitin-positive DS along the posterior spinocerebellar tract and the white matter of certain lobes of cerebellum. In 18th week, the transneuronal degeneration started from the distal axonal ends of the primary sensory neurons came up to the some parts of cortical neurons through the secondary neurons in the thalamus. The ubiquitin-positive DS were detected on the ventral surface of the medulla oblongata and increased progressively in number along the corticospinal (pyramidal) tract of spinal cord which consists of the descending fibers derived from the cortical neurons. These findings suggest that abnormal proteins in the degenerating axons were ubiquitinated rapidly before they accumulated in the preterminal axons whose neuron stems are far away from the place, and that GAD mouse would be a useful animal model to know the mechanism(s) of the naturally occurring transneuronal degeneration from the distal axonal ends of both ascending sensory neurons and descending pyramidal neurons in the CNS.
Collapse
Affiliation(s)
- J Wu
- Department of Animal Models for Human Disease, National Institute of Neuroscience, NCNP, Tokyo, Japan
| | | | | | | | | |
Collapse
|
43
|
Motoyama M, Imaoka T, Ichihara N, Miyauchi S. [Effect of BOF-A2 on experimental and spontaneous metastasis model of mouse colon 26]. Gan To Kagaku Ryoho 1994; 21:1209-14. [PMID: 8031163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
We investigated the effects of BOF-A2 on the metastasis of colorectal cancer using artificial (experimental) and spontaneous metastasis of Colon 26 tumor cells. BOF-A2 suppressed pulmonary nodules in the artificial metastasis of Colon 26 tumor cells into the lung, and the T/C (%) was 53.1% at 20 mg/kg or 8.3% at 40 mg/kg. BOF-A2 also suppressed pulmonary nodules in the spontaneous metastasis of Colon 26 tumor cells into the lung, and the T/C (%) was 33.3% at 40 mg/kg in postoperative treatment, 33.3% at 10 mg/kg, or 16.7% at 20 mg/kg in preoperative treatment. These effects were accompanied by the prolongation of survival time at each dose. From these results, BOF-A2 showed antimetastatic activity and survival effect, and may be useful for adjuvant chemotherapy to prevent cancer from metastasis to the lung.
Collapse
Affiliation(s)
- M Motoyama
- Fujii Memorial Research Institute, Otsuka Pharmaceutical Co., Ltd
| | | | | | | |
Collapse
|
44
|
Yamazaki K, Moriya H, Ichihara N, Mitsushio H, Inagaki S, Kikuchi T. Substance P-immunoreactive astrocytes in gracile sensory nervous tract of spinal cord in gracile axonal dystrophy mutant mouse. Mol Chem Neuropathol 1993; 20:1-20. [PMID: 7504492 DOI: 10.1007/bf03160066] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
In the gracile axonal dystrophy (GAD) mutant mouse, the dying-back type axonal dystrophy of the primary afferent neurons in the gracile tract of the spinal cord was marked by severe gliosis characterized by the hypertrophy and proliferation of the fibrous astrocytes. Immunocytochemical observation for substance P (SP) revealed that SP-positive cells increased in the lesioned sites, primarily in the gracile nucleus of the medulla and subsequently in the gracile fasciculus of the spinal cord. The combined immunostaining of both SP and glial fibrillary acidic protein (GFAP) indicated that a strong correspondence exists between GFAP-positive networks and SP-positive grains, suggesting that SP was accumulated in the cytoplasm of astrocytes. The networks of SP-positive astrocytes spread all over the gracile tract and were densest at the subpial membrane. Similar lesions and SP activity were detected along the marginal zone of the lateral and ventral funiculi. Using an electron microscope, in addition to SP-positive axonal terminals in the gracile nucleus, most SP-positive cells in the gracile tract were identified as reactive astrocytes whose processes surrounded myelinated and nonmyelinated axons, and extended their foot processes to the blood vessels. By in situ hybridization histochemistry of SP mRNA, we confirmed the synthesis of SP in the astrocytes. Although the functional significance of SP within astrocytes is not established here, these results imply that the astrocytes may play a role as a gliotransmitter through which the progress of axonal degeneration in the spinal cord was modified.
Collapse
Affiliation(s)
- K Yamazaki
- Division of Animal Models for Human Disease, National Institute of Neuroscience, NCNP, Tokyo, Japan
| | | | | | | | | | | |
Collapse
|
45
|
Kawamura T, Ichihara N, Sugiyama S, Yokota H, Ishimoto N, Ito E. Biosynthesis of UDP-N-acetyl-D-glucosaminuronic acid and UDP-N-acetyl-D-mannosaminuronic acid in Micrococcus luteus. J Biochem 1985; 98:105-16. [PMID: 4044544 DOI: 10.1093/oxfordjournals.jbchem.a135248] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
The occurrence and formation of UDP-N-acetyl-D-glucosaminuronic acid (UDP-GlcNAcA) and UDP-N-acetyl-D-mannosaminuronic acid (UDP-ManNAcA) were studied in Micrococcus luteus ATCC 4698. UDP-N-acetylhexosaminuronic acid separated from D-cycloserine-inhibited cells was shown to be a mixture of UDP-GlcNAcA and UDP-ManNAcA in the ratio of 87:13, whereas that obtained from untreated cells was a 96:4 mixture of these two nucleotides. Crude enzyme preparations obtained from the supernatant fraction of cells catalyzed the NAD+-dependent conversion of UDP-GlcNAc into UDP-GlcNAcA and UDP-ManNAcA. Studies on the partial separation and properties of enzymes revealed that UDP-GlcNAcA is synthesized directly from UDP-GlcNAc by the action of UDP-GlcNAc dehydrogenase and that UDP-ManNAcA is synthesized from UDP-GlcNAc through the successive actions of UDP-GlcNAc 2-epimerase and UDP-ManNAc dehydrogenase. However, enzymatic conversion of UDP-GlcNAcA to UDP-ManNAcA was not detected. Ammonium sulfate protects both dehydrogenases from inactivation during storage and incubation. Partially purified UDP-GlcNAc dehydrogenase required dithiothreitol and the particulate fraction for its full activity. The apparent Km values of UDP-GlcNAc dehydrogenase for UDP-GlcNAc and NAD+ were 0.28 and 1.43 mM, respectively. The optimum pH of this enzyme was higher than 9 in Tris-HCl buffer. p-Chloromercuribenzoate at 27 microM as well as 10 mM ethanol almost completely inhibited the UDP-GlcNAc dehydrogenase reaction.
Collapse
|
46
|
Oyanagi K, Nakata F, Hirano S, Sogawa H, Takayanagi N, Minami R, Tsugawa S, Nakao T, Ichihara N. Uridine diphosphate galactose 4-epimerase deficiency. Eur J Pediatr 1981; 135:303-4. [PMID: 7227386 DOI: 10.1007/bf00442108] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
A case of uridine diphosphate galactose (UDP-Gal) 4-epimerase deficiency was discovered by mass screening of newborn infants. UDP-Gal 4-epimerase activity of red blood cells from the patient was found to be remarkably low, i.e., 7.5% of the level in normal controls at comparable ages. The parents showed intermediate values between those of the patient and controls. The enzyme activity in a specimen of liver tissue obtained from the patient by needle biopsy revealed a normal value. Subsequently, two other families with the condition were found by mass screening and these individuals were found to be heterozygotes.
Collapse
|
47
|
Kawamura T, Ichihara N, Ishimoto N, Ito E. Biosynthesis of uridine diphosphate N-acetyl-D-mannosaminuronic acid from uridine diphosphate N-acetyl-D-glucosamine in Escherichia coli: separation of enzymes responsible for epimerization and dehydrogenation. Biochem Biophys Res Commun 1975; 66:1506-12. [PMID: 1103893 DOI: 10.1016/0006-291x(75)90529-x] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
48
|
Ichihara N, Ishimoto N, Ito E. Enzymatic incorporation of N-acetyl-D-mannosaminuronic acid and D-glucose into a polysaccharide of Escherichia coli 314 K7 H minus. FEBS Lett 1974; 40:309-11. [PMID: 4604435 DOI: 10.1016/0014-5793(74)80251-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
49
|
|